BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33359267)

  • 1. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
    Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
    Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy.
    Li Y; Fan X; Yu Q; Zhai H; Mo M; Sun J; Mi J; Lu R; Mao J; Chen J; Ma N; Yang W; Zhu J; Jiang G; Wu K
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):579-589. PubMed ID: 36586495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis.
    Kim N; Noh JM; Lee W; Park B; Pyo H
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
    Iocolano M; Yegya-Raman N; Friedes C; Wang X; Kegelman T; Lee SH; Duan L; Li B; Levin WP; Cengel KA; Konski A; Langer CJ; Cohen RB; Sun L; Aggarwal C; Doucette A; Xiao Y; Kevin Teo BK; O'Reilly S; Zou W; Bradley JD; Simone CB; Feigenberg SJ
    Cancer; 2024 Jun; 130(11):2031-2041. PubMed ID: 38294959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on circulating blood cells.
    Kim N; Shin J; Ahn SH; Pyo H; Noh JM; Yang K; Lee W; Park B
    Front Oncol; 2023; 13():1119173. PubMed ID: 36923437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
    Shiraishi Y; Fang P; Xu C; Song J; Krishnan S; Koay EJ; Mehran RJ; Hofstetter WL; Blum-Murphy M; Ajani JA; Komaki R; Minsky B; Mohan R; Hsu CC; Hobbs BP; Lin SH
    Radiother Oncol; 2018 Jul; 128(1):154-160. PubMed ID: 29248170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Liao Z; Lee JJ; Komaki R; Gomez DR; O'Reilly MS; Fossella FV; Blumenschein GR; Heymach JV; Vaporciyan AA; Swisher SG; Allen PK; Choi NC; DeLaney TF; Hahn SM; Cox JD; Lu CS; Mohan R
    J Clin Oncol; 2018 Jun; 36(18):1813-1822. PubMed ID: 29293386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.
    Cortiula F; Hendriks LEL; Wijsman R; Houben R; Steens M; Debakker S; Canters R; Trovò M; Sijtsema NM; Niezink AGH; Unipan M; Urban S; Michelotti A; Dursun S; Bootsma G; Hattu D; Nuyttens JJ; Moretti E; Taasti VT; De Ruysscher D
    Radiother Oncol; 2024 Jan; 190():110019. PubMed ID: 38000689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era.
    Byun HK; Kim N; Yoon HI; Kang SG; Kim SH; Cho J; Baek JG; Chang JH; Suh CO
    Radiat Oncol; 2019 Mar; 14(1):51. PubMed ID: 30917849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.
    Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R
    Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
    Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
    Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
    Xi M; Xu C; Liao Z; Chang JY; Gomez DR; Jeter M; Cox JD; Komaki R; Mehran R; Blum MA; Hofstetter WL; Maru DM; Bhutani MS; Lee JH; Weston B; Ajani JA; Lin SH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):667-676. PubMed ID: 29280461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in lung injury after IMRT or proton therapy assessed by
    Shusharina N; Liao Z; Mohan R; Liu A; Niemierko A; Choi N; Bortfeld T
    Radiother Oncol; 2018 Jul; 128(1):147-153. PubMed ID: 29352608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
    Wang XS; Shi Q; Williams LA; Komaki R; Gomez DR; Lin SH; Chang JY; O'Reilly MS; Bokhari RH; Cox JD; Mohan R; Cleeland CS; Liao Z
    J Pain Symptom Manage; 2016 May; 51(5):832-8. PubMed ID: 26891607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
    Mohan R; Liu AY; Brown PD; Mahajan A; Dinh J; Chung C; McAvoy S; McAleer MF; Lin SH; Li J; Ghia AJ; Zhu C; Sulman EP; de Groot JF; Heimberger AB; McGovern SL; Grassberger C; Shih H; Ellsworth S; Grosshans DR
    Neuro Oncol; 2021 Feb; 23(2):284-294. PubMed ID: 32750703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
    Walser MA; Bachmann N; Kluckert J; Köthe A; Tully C; Leiser D; Lomax AJ; Bizzocchi N; Langendijk JA; Weber DC
    Br J Radiol; 2023 Aug; 96(1148):20220672. PubMed ID: 37129312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.